August 14, 2009 — Labeling information on prescription drugs and medical devices should be expanded to include comparative effectiveness, according to a perspective article published online August 12 ...

As benchmarking is now becoming a part of payment models, practices realize they need comparative data to understand how well they perform relative to their competitors and whether there is room for ...

Only about half of new drugs approved in the last decade had comparative effectiveness data available at the time of their approval by the US Food and Drug Administration, and approximately two-thirds ...

What happens when a government agency in charge of assessing the effectiveness of medical interventions crunches numbers and tells pharmaceutical companies their drugs are just too expensive?

James C. Robinson ( [email protected]) is the Kaiser Permanente Professor of Health Economics at the School of Public Health, University of California, Berkeley. Comparative effectiveness research has ...

With a vision of offering the most robust drug information resources on the market, Wolters Kluwer Health has been bringing together the strongest clinical content and tools from its referential ...

Difficult employment issues can arise during an international business purchase and what is straightforward in one country can prove challenging in another. Our new cross-border tool provides a quick ...

The increasing integration of qualitative and quantitative analysis has largely focused on the benefits of in-depth case studies for enhancing our understanding of statistical results. This article ...

Nokia provides recast comparative quarterly financial information reflecting the transfer of Managed Services business from Cloud and Network Services to Mobile NetworksNokia today provided recast ...

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...